LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 213 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $380 | +2.4% | 5,190 | 0.0% | 0.00% | 0.0% |
Q4 2023 | $371 | +19.3% | 5,190 | 0.0% | 0.00% | 0.0% |
Q3 2023 | $311 | -16.8% | 5,190 | 0.0% | 0.00% | -25.0% |
Q2 2023 | $374 | +3.6% | 5,190 | +5.7% | 0.00% | 0.0% |
Q1 2023 | $361 | +10.1% | 4,909 | 0.0% | 0.00% | +33.3% |
Q4 2022 | $328 | -99.9% | 4,909 | -10.6% | 0.00% | -50.0% |
Q3 2022 | $473,000 | -19.1% | 5,489 | +5.6% | 0.01% | 0.0% |
Q1 2022 | $585,000 | -27.1% | 5,200 | 0.0% | 0.01% | -14.3% |
Q4 2021 | $803,000 | +43.4% | 5,200 | +29.3% | 0.01% | +40.0% |
Q3 2021 | $560,000 | +180.0% | 4,021 | +164.4% | 0.01% | +150.0% |
Q2 2021 | $200,000 | -13.8% | 1,521 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $232,000 | +53.6% | 1,521 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $151,000 | -41.7% | 1,521 | -44.1% | 0.00% | -33.3% |
Q3 2020 | $259,000 | -26.4% | 2,722 | -13.6% | 0.00% | -25.0% |
Q2 2020 | $352,000 | +53.7% | 3,150 | 0.0% | 0.00% | +33.3% |
Q1 2020 | $229,000 | -43.7% | 3,150 | -19.2% | 0.00% | -25.0% |
Q4 2019 | $407,000 | +4.9% | 3,900 | 0.0% | 0.00% | -20.0% |
Q3 2019 | $388,000 | -17.8% | 3,900 | -5.8% | 0.01% | -16.7% |
Q2 2019 | $472,000 | -34.5% | 4,140 | -27.9% | 0.01% | -33.3% |
Q1 2019 | $721,000 | -13.4% | 5,740 | -6.5% | 0.01% | -18.2% |
Q4 2018 | $833,000 | -52.9% | 6,140 | -4.7% | 0.01% | -47.6% |
Q3 2018 | $1,768,000 | +28.5% | 6,440 | -3.0% | 0.02% | +31.2% |
Q2 2018 | $1,376,000 | +25.4% | 6,640 | 0.0% | 0.02% | +23.1% |
Q1 2018 | $1,097,000 | +35.8% | 6,640 | +12.5% | 0.01% | +44.4% |
Q4 2017 | $808,000 | +0.6% | 5,900 | 0.0% | 0.01% | -10.0% |
Q3 2017 | $803,000 | +12.2% | 5,900 | 0.0% | 0.01% | +11.1% |
Q2 2017 | $716,000 | +7.3% | 5,900 | -6.3% | 0.01% | +12.5% |
Q1 2017 | $667,000 | -6.2% | 6,300 | -10.0% | 0.01% | -11.1% |
Q4 2016 | $711,000 | -5.8% | 7,000 | -5.4% | 0.01% | -10.0% |
Q3 2016 | $755,000 | -14.5% | 7,400 | 0.0% | 0.01% | -16.7% |
Q2 2016 | $883,000 | +11.5% | 7,400 | 0.0% | 0.01% | +20.0% |
Q1 2016 | $792,000 | +4.3% | 7,400 | +5.7% | 0.01% | 0.0% |
Q4 2015 | $759,000 | +45.4% | 7,000 | +14.8% | 0.01% | +42.9% |
Q3 2015 | $522,000 | -15.1% | 6,100 | 0.0% | 0.01% | 0.0% |
Q2 2015 | $615,000 | +30.9% | 6,100 | 0.0% | 0.01% | +40.0% |
Q1 2015 | $470,000 | +44.6% | 6,100 | 0.0% | 0.01% | +25.0% |
Q4 2014 | $325,000 | +13.2% | 6,100 | 0.0% | 0.00% | +33.3% |
Q3 2014 | $287,000 | -24.5% | 6,100 | 0.0% | 0.00% | -25.0% |
Q2 2014 | $380,000 | -15.7% | 6,100 | -9.0% | 0.00% | -20.0% |
Q1 2014 | $451,000 | +28.1% | 6,700 | 0.0% | 0.01% | +25.0% |
Q4 2013 | $352,000 | – | 6,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 353,041 | $25,673,000 | 16.20% |
Stonepine Capital Management, LLC | 160,919 | $11,702,000 | 12.38% |
VILLERE ST DENIS J & CO LLC | 635,758 | $46,232,000 | 3.94% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 982,049 | $71,415,000 | 3.51% |
Elk Creek Partners, LLC | 246,251 | $17,907,000 | 3.08% |
Tygh Capital Management, Inc. | 151,792 | $11,038,000 | 2.47% |
Roubaix Capital, LLC | 20,034 | $1,457,000 | 2.21% |
Conestoga Capital Advisors, LLC | 648,603 | $47,166,000 | 1.38% |
RICE HALL JAMES & ASSOCIATES, LLC | 338,376 | $24,607,000 | 1.38% |
Ikarian Capital, LLC | 200,000 | $14,544,000 | 1.09% |